PDAC-associated K-RAS alterations mainly harbour missense mutations that depend on allele dosage for tumorigenesis and metastasis onset, and contribute to PDAC evolution from PanINs to final cancer formation with the loss of other key PDAC-driving players [24]. This evidence concerns the gene KRAS and cancer.